NBP226240
Novus Biologicals™ CpG oligodeoxynucleotides Mouse
Manufacturer: Novus Biologicals™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP226240-Each-of-1 | In Stock | ₹ 40,050.00 |
NBP226240 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 40,050.00
GST (18%): ₹ 7,209.00
Total Price: ₹ 47,259.00
Content And Storage
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Quantity
5 Vials
For Use With (Application)
Activation of mouse TLR9
Type
CpG Oligodeoxynucleotides
Compare Similar Items
Show Difference
Content And Storage: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Quantity: 5 Vials
For Use With (Application): Activation of mouse TLR9
Type: CpG Oligodeoxynucleotides
Content And Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Quantity:
5 Vials
For Use With (Application):
Activation of mouse TLR9
Type:
CpG Oligodeoxynucleotides
Content And Storage: Store at -20°C. Avoid freeze-thaw cycles.
Quantity: 5 g
For Use With (Application): __
Type: __
Content And Storage:
Store at -20°C. Avoid freeze-thaw cycles.
Quantity:
5 g
For Use With (Application):
__
Type:
__
Content And Storage: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Quantity: 2 Vials
For Use With (Application): The inhibitor is used in assays to inhibit TLR4 activation; see Figure 3 and also refer to Lysakova-Devine et al (2010) for examples. Optimal inhibitor concentrations should be established through titration and may vary between model systems. We recommend an initial titration from 0-30 uM for in vitro assays (Fig 3). Control concentrations should mirror inhibitor concentrations. Inhibitor and control should be preincubated with cells prior to ligand activation to allow sufficient time for the peptides to enter from the media into the cell. We typically preincubate with inhibitor and control peptides for 2 h prior to TLR4 activation with LPS (Fig 3); however, optimal preincubation times may vary between model systems. The TLR4/MD-2/CD14 stably transfected cell line is a useful positive control model system for studying inhibition of TLR4 activation by VIPER (Fig 3). SEAP is used as a readout assay in Figure 3 to measure TLR4 inhibition. A novel model system is shown in Figure 1 where TL
Type: __
Content And Storage:
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Quantity:
2 Vials
For Use With (Application):
The inhibitor is used in assays to inhibit TLR4 activation; see Figure 3 and also refer to Lysakova-Devine et al (2010) for examples. Optimal inhibitor concentrations should be established through titration and may vary between model systems. We recommend an initial titration from 0-30 uM for in vitro assays (Fig 3). Control concentrations should mirror inhibitor concentrations. Inhibitor and control should be preincubated with cells prior to ligand activation to allow sufficient time for the peptides to enter from the media into the cell. We typically preincubate with inhibitor and control peptides for 2 h prior to TLR4 activation with LPS (Fig 3); however, optimal preincubation times may vary between model systems. The TLR4/MD-2/CD14 stably transfected cell line is a useful positive control model system for studying inhibition of TLR4 activation by VIPER (Fig 3). SEAP is used as a readout assay in Figure 3 to measure TLR4 inhibition. A novel model system is shown in Figure 1 where TL
Type:
__
Content And Storage: Store at 4°C. Do not freeze.
Quantity: 1 Kit
For Use With (Application): Flow Cytometry
Type: __
Content And Storage:
Store at 4°C. Do not freeze.
Quantity:
1 Kit
For Use With (Application):
Flow Cytometry
Type:
__